Aim-To investigate the prevalence, distribution, and clinical details of pa
ediatric hepatitis C virus (HCV) infection in the UK and Ireland.
Methods-Active monthly surveillance questionnaire study coordinated through
the British Paediatric Surveillance Unit, to all consultant paediatricians
in 1997 and 1998.
Results-A total of 182 I-PCV infected children were reported from 54 centre
s and by paediatricians from eight different specialties. In 40 children HC
V was acquired through mother to child transmission (MTC children); 142 wer
e infected by contaminated blood products (n = 133),organ transplantation (
n = 2), needles (n = 4), or unknown risk factor (n = 2). Intravenous drug u
se was the risk factor for 35 mothers of MTC children. Twelve children were
coinfected with HIV and four with HBV. Recent serum aspartate aminotransfe
rase or alanine aminotransferase values were at least twofold greater than
the upper limit of normal in 24 of 152 children; this occurred in five of 1
1 HIV coinfected children. Liver histology, available in 53 children, showe
d normal (7%), mild (74%), moderate (17%), or severe (2%) hepatitis. Twenty
eight children had received therapy with interferon alfa.
Conclusion-Most current paediatric HCV infection in UK and Ireland has been
acquired from contaminated blood products, and most children are asymptoma
tic. There is a need for multicentre trials to inform clinical practice and
development of good practice guidelines in this area. Long term follow up
of this cohort of HCV infected children is planned to help determine the na
tural history over the long term of HCV acquired during infancy and childho
od.